Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation.
Journal: Leukemia & lymphoma
Published: August 07, 2026
Pegylated Interferons: Still a Major Player for the Treatment of Myeloproliferative Neoplasms.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 30, 2025
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.
Journal: Blood advances
Published: March 22, 2024
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: September 04, 2023
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 14, 2022
The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study.
Journal: Leukemia & lymphoma
Published: March 03, 2021
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Journal: American journal of hematology
Published: June 01, 2020
Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol.
Journal: Research in nursing & health
Published: May 21, 2020
Last Updated: 09/26/2026